MD Anderson 2020 Update on IO for Metastatic Melanoma: What Is the 5-Year OS With Single-Agent PD-1 & PD-/CTLA-4 Agents? Which Options to Consider After Progression on PD-1(+/- Ipi)?
Comments 0
Login to view comments.
Click here to Login
